chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chills, Feeling abnormal, Pyrexia, SARS-CoV-2 test
Clinical narrative: tested Covid positive; fever; Chills; feel funny/felt loopy; This is a spontaneous report received from a contactable consumer, the patient.  A 52-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: ER8733; Expiration Date: 31Jul2021) via an unspecified route of administration, administered in Arm Right on 26Mar2021 15:15 as dose 1, single for covid-19 immunisation (52 years age at vaccination). Medical history was reported as none. There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient did not receive any other vaccine on the same date of Pfizer vaccine. The patient was not diagnosed with COVID-19 Prior to vaccination. The patient had not been tested for COVID-19 Since the vaccination. On 26Mar2021, Patient felt funny/felt loopy, on 27Mar2021, she had fever, chills and on 30Mar2021, the patient tested covid positive. She got the first dose of the Pfizer Covid vaccine last Friday 26Mar2021 around 15:15 PM, states that she experienced side effects starting Saturday evening, 27Mar2021, states she had fever and chills, which were side effects that she read about and she took Tylenol to treat them and everything was fine, states that she noticed she went to school on Monday and talked to her principal and explained to her she got the shot and her principal said she did not look right and she decided to go home, states when she went home her husband was not feeling right so he decided to go get tested and she decided to get tested as well for Covid virus, states she tested positive for the virus on Tuesday, 30Mar2021. States it was a possibility she had it before and did not know, she had no symptoms prior to the vaccine. She stated she knew the vaccine can't give someone a Covid infection. She asked, if she need to wait 90 days before getting the second dose. The patient underwent lab tests and procedures which included Covid test: positive on 30Mar2021. Therapeutic measures Tylenol were taken as a result of fever and chills. Patient did not go to emergency room or physician's office due to adverse events. The event fever was resolved on 28Mar2021 and outcome of events covid-19 and chills was not recovered and for feeling funny and loopy the outcome was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Dysphagia, Hypersensitivity, Tremor
Clinical narrative: allergic reaction; couldn't swallow; shaking; This is a spontaneous report received from a contactable consumer (patient) via Pfizer sponsored program. A 55-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on an unspecified date (at the age of 55-year-old) as DOSE 1, SINGLE for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Patient stated, went on Sunday and had first Covid shot and they do not know if she had an allergic reaction or not. She went to ER and got prednisone and Benadryl. She was shaking (on an unspecified date) and got to where she could not swallow but they said there was nothing swollen. Stated, physician could not tell if she should get the second dose or not and told me to call you. Patient again stated, she should get the second dose of Pfizer vaccine or take Benadryl before getting the vaccine because she had an allergic reaction after the first dose and could not swallow (on an unspecified date). Therapeutic measures were taken as a result of allergic reaction, couldn't swallow, shaking. The outcome of events was unknown.   Information on lot number/batch number was requested.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Pyrexia
Clinical narrative: Fever (maximum 102F); chest pain,central breast bone lasting approximately 4 hours; This is a spontaneous report from a contactable consumer.   A 23-years-old non pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number and Expiration date was not reported), via an unspecified route of administration, administered in Arm Right on 30Mar2021 12:30 (Age at vaccination 23 years) as dose 2, single for covid-19 immunisation.  Medical history included migraine. Concomitant medications included fremanezumab (AJOVY [FREMANEZUMAB]), depovera. Patient had allergic to amoxicillin. Patient previously took bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) dose 1 on 09Mar2021 12:30 for covid-19 immunization. The patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 08:30 The patient experienced fever (maximum 102f), chest pain, central breastbone lasting approximately 4 hours. The patient underwent lab tests and procedures which included pyrexia was (maximum 102f) on 31Mar2021. Patient did not receive any treatment. On an unspecified date in 2021, the patient had recovered from the events.  No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Fatigue, Headache, Myalgia, Pain
Clinical narrative: This is a spontaneous report from a non-contactable consumer or other non hcp (patient). A 42-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 24Mar2021 15:00 (Batch/Lot Number: EL3248) as dose 2, single, dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. No known allergy. No other medical history. The patient was not pregnant at the time of vaccination. On 25Mar2021(13 hour after injection), the patient experienced mild fever, body aches, muscle soreness, headache, fatigue, some swelling initially at injection site leading to pain under left armpit area. Therapeutic measures were taken as a result of event includes TYLENOL. The outcome for all events was recovered on unknown date in 2021. No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site swelling
Clinical narrative: This is a spontaneous report from a non-contactable consumer or other non hcp (patient). A 42-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 24Mar2021 15:00 (Batch/Lot Number: EL3248) as dose 2, single, dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. No known allergy. No other medical history. The patient was not pregnant at the time of vaccination. On 25Mar2021(13 hour after injection), the patient experienced mild fever, body aches, muscle soreness, headache, fatigue, some swelling initially at injection site leading to pain under left armpit area. Therapeutic measures were taken as a result of event includes TYLENOL. The outcome for all events was recovered on unknown date in 2021. No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Joint swelling, Peripheral swelling
Clinical narrative: swelling in knuckle between distal and medial phalanges on the middle, ring, and pinky fingers of the right hand.; Joints are also hot to the touch and finger tips are visibly swollen; Joint pain and swelling in knuckle between distal and medial phalanges on the middle, ring, and pinky fingers of the right hand.  Joints are also hot to the touch and finger tips are visibly swollen.; This is a spontaneous report from a contactable healthcare professional, the patient. A 36-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3249) via an unspecified route of administration on 21Jan2021 (at the age of 36-years-old) as single dose for COVID-19 immunisation. Medical history included plica syndrome in the left knee. The patient was known allergic to augmentin and mushrooms. The patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EK9231) via intramuscular route of administration on the right arm on 31Dec2020 (at the age of 36-years-old) as single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since vaccination, the patient had not been tested  positive for COVID-19. Concomitant medications were not reported.  The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Mar2021, the patient experienced joint pain and swelling in knuckle between distal and medial phalanges on the middle, ring, and pinky fingers of the right hand and the joints were also hot to the touch and finger tips were visibly swollen. The patient did not receive any treatment for the events.  The events didn't resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events joint pain and swelling in knuckle between distal and medial phalanges on the middle, ring, and pinky fingers of the right hand and swollen finger tips was not recovered at the time of this report. No follow-up attempts are needed; no further information is expected.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure measurement, Hypertension
Clinical narrative: BP increased to 215/115 before I went to ER and then administered intravenous drugs and nitroglycerin cream over heart area.; This is a spontaneous report received from agency, This is a spontaneous report from a contactable consumer or other non-health care professional. A 51-years-old male patient received dose of bnt162b2 (BNT162B2, solution for injection, Batch/Lot Number: EP6955) via an unspecified route of administration and administered in left arm on 22Mar2021 12:30 as 1 st dose, single for COVID-19 immunization. The patient didnot receive any other vaccines within 4 weeks prior to the COVID vaccine and didnot have any allergies to medications, food, or other products. The patient was not diagnosed with COVID-19 prior to vaccination and since vaccination patient didnot test for COVID-19. The patient medical history includes border hypertension. The patients concomitant medication included lisinopril (LISINOPRIL) 20mg and it was other medications the patient received within 2 weeks of vaccination. The patient experienced increased in blood preasure to 215/115 before he went to Emergency room/department or urgent care on 22Mar2021 and then treated with intravenous drugs and nitroglycerin cream over heart area. The outcome of event was recovered.  No follow-up attempts are possible; information about batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: tested positive for Covid-19; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration on 06Mar2021 (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported that the patient and her husband received their first Pfizer Covid vaccine dose on 06Mar2021. On 09Mar2021 they both tested positive for Covid-19. She stated they were both negative now. She stated that her husband had to be hospitalized and an infectious disease. They had both tested negative since then. MD told her that they should wait 90 days and try to start over again with another series of Covid vaccines. She wanted further guidance for her situation. They were scheduled for the second one and she was asking if they should still get the second covax. The HCP from the hospital told vaccine was breached. Caller enquired, if we waited 90 days after the first dose, should we start over with a whole new series of vaccines. Outcome of the event was recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: Received the first dose of the Pfizer COVID vaccine on 15Mar2021 /then positive on 31Mar2021; Received the first dose of the Pfizer COVID vaccine on 15Mar2021 /then positive on 31Mar2021; This is a spontaneous report received from a contactable consumer (patient) via Pfizer-sponsored program Support. A 48-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), Solution for injection, via an unspecified route of administration on 15Mar2021 (Batch/Lot number was not reported) as first dose, single for COVID-19 immunization. Medical history and concomitant medications were not reported. Patient stated she was scheduled to receive the second dose on 05Apr2021. Patient reported that she began to have symptoms of COVID-19 on 29Mar2021 and she tested negative for COVID on 30Mar2021 and then positive on 31Mar2021. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 30Mar2021, sars-cov-2 test: positive on 31Mar2021. Patient wanted to know if there was any data available for a fully vaccinated person who contracted a mild case of the virus and would the vaccination prevent them from giving the vaccination to others and also if the vaccine can be delayed to four weeks if needed due to her COVID-19 diagnosis. The outcome events was unknown.  Information about lot/batch number has been requested.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Diarrhoea, Fatigue, Lymphadenopathy, Pain in extremity
Clinical narrative: Diarrhea; Had persistent diarrhea which has gotten worse; Arm was sore; Tired; Swollen glands; This is a spontaneous report from a contactable consumer (patient, self-reporting). A 69-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot Number: EL1283 and expiration date was not reported), via an unspecified route of administration, administered in left arm on 19Jan2021 (at the age of 69-year-old) as dose 1, single for COVID-19 immunisation.  Medical history included breast cancer female from an unknown date the caller was on a breast cancer drug trial and has been on it for 17 years. Concomitant medications included levothyroxine taken for an unspecified indication from an unspecified start date and ongoing, estriol, estradiol, testosterone, progesterone, dhea, estrone taken for breast cancer female, start and stop date were not reported. On 20Jan2021 after the first vaccine she noticed she had some swollen glands. About three days after the first vaccine caller started experiencing diarrhea. The caller has had persistent diarrhea and her doctor asked her when she got the vaccine and she realized she has had the diarrhea since about 3-4 days after the first vaccine. The caller has had persistent diarrhea which has gotten worse, and it didn't go away. The caller tried one prescription, diphenoxylate atropine 2.5 mg tablets and it didn't do it, it would slow down the diarrhea but would not stop it. This medicine was in a pharmacy bottle, unknown lot, expiration date 15Feb22. The second prescribed medication, prevalite, has been working well but as soon as she tries to wean off it, the diarrhea comes back with a vengeance. The caller has called around to get an appointment with a gastrointestinal specialist but 28Jul2021 is the soonest appointment she can get. The caller's doctor suspects the diarrhea is related to the vaccine.   Therapeutic measures were taken as a result of diarrhea. Outcome for the event lymphadenopathy was recovered, Diarrhoea was not recovered, condition aggravated, pain in extremity, fatigue was unknown.  No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: I received the vaccine this past Monday 29 Mar 2021, and tested positive; This is a spontaneous report from a contactable consumer (patient herself) via Pfizer Sponsored Program . A female patient of an unspecified age received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- UNKNOWN) via an unspecified route of administration on 29Mar2021 as dose 1, single for COVID-19 immunization. Patient medical history and concomitant medications were not reported. Patient received the vaccine this past Monday (29Mar2021) and tested positive on an unspecified date in 2021, how did that affect her from getting her second dose, she asked. Any unaddressed medical questions were not referred or forwarded to Medical Information. The outcome of the event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: tested positive for covid19 after receiving vaccine; This is a spontaneous report from a contactable consumer or other non hcp.   A female patient of an unspecified age received first dose of bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot number: not reported), via an unspecified route of administration on Mar2021 as dose 1, single for covid-19 immunization. The patient medical history and concomitant medications. On an unknown date, the patient tested positive for covid19 after receiving vaccine, coughing and did not feel super well. It was reported that when mentioning contacts, reporter stated his boss had friends over, she got her vaccine last Friday, but she was in contact with someone. It was a huge house and people were all around and they did not have waiters because caller had nobody to serve them. reporter was very conscious, he added that maybe her boss went out and got contact with someone. Reporter's boss did not tell him or anything and added that his boss obviously got the virus on the Monday night, she did not feel super well and on Tuesday, his boss was coughing a little bit and she went to go get the test and tested positive. She tested positive on Monday morning. They did PCR test and she was positive. Reporter does not want to report on his boss, she will probably do it on her own. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on unknown date. The outcome of event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: three hours later spiked a fever of 103.2.; I had chills; strong chills with teeth; This is a spontaneous report from a contactable consumer. A 57-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EN8730 and expiration date was not reported), second dose via an unspecified route of administration, administered in arm left on 31Mar2021 11:00 (at the age of 57 years) single dose for covid-19 immunisation. Patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EN6206 and expiration date was not reported) first dose via an unspecified route of administration, administered in arm left on 09Mar2021 15:30 single dose for covid-19 immunisation. Patient was not pregnant at the time of vaccination. Medical history included drug hypersensitivity for Penicillin & erythromycin from an unknown date and unknown if ongoing. Concomitant medication(s) included ibuprofen and Multi Vitamin taken for an unspecified indication, start and stop date were not reported. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient was not diagnosed with COVID-19, prior vaccination and since the vaccination. On 01Apr2021 12:00 the patient experienced chills, took Tylenol and three hours later spiked a fever of 103.2. It didn't last long and didn't had the normal strong chills with teeth chattering. The clinical outcome of the events were recovering.  Information on the lot/batch number cannot be requested.  Follow-up (13May2021): Follow-up attempts completed. No further information expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Nausea, Pyrexia
Clinical narrative: Fever; Headache; Nausea; Chills; This is a spontaneous report from non-contactable consumer reported for herself. A 33-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Lot number: Ew0150, Expiry date: not reported) via an unspecified route of administration in left arm on 31Mar2021 at 19:15 (at the age of 33-years-old) as dose 1, single for COVID-19 Immunization. The patient medical history and concomitant medications were not reported. Patient did not have any allergies to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 01Apr2021 at 08:00 (one day after vaccination), patient had experienced fever, headache, nausea, chills. Patient did not receive any treatment for the adverse event. The outcome of events was recovered on an unspecified date in 2021.   No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: PPV
Symptoms: Extra dose administered, Therapeutic response decreased
Clinical narrative: low responder to the Pneumococcal vaccine and has to get extra.; This is a spontaneous report received from a non-contactable consumer (patient's mother) via Team. A 15-year-old male patient received pneumococcal 13-valent conjugated vaccine (diphtheria crm197 protein) (Solution for injection in pre-filled syringe; Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose number, unknown for immunisation. The patient medical history and concomitant medications were not reported. It was reported that, the patient was low responder to the pneumococcal vaccine and has to get extra on an unspecified date. The outcome of the event was reported as unknown.  No follow-up attempts are possible. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: fatigue; sore arm; This is a spontaneous report received from a non- contactable consumer (patient). A 31-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection) via an unspecified route of administration, administered in Arm Right on 31Mar2021 (at the age of 31-years-old) as single dose for covid-19 immunization. The patient's medical history was not reported. The patient previously received first dose of bnt162b2 (at the age of 31-years-old) for covid-19 immunization. The patient's concomitant medications were not reported. The patient experienced fatigue and sore arm on 31Mar2021. The outcome of the event was recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Pain, Pyrexia
Clinical narrative: This is a spontaneous case received from a contactable consumer (patient). A 52-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection, #lot: EL3248) via an unspecified route of administration administered in Arm Left on 30Mar2021 15:30 (at the age of 52-years-old) as single dose for COVID-19 immunization. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection, #lot: EL3248) via an unspecified route of administration administered in Arm Left on 09Mar2021 15:15 (at the age of 52-years-old) as single dose for COVID-19 immunization and allergies to medications, food, or other products with amoxicillin. The patient's concomitant medications included loratadine (CLARITINE). It was reported that the patient became aware of the AE on 31Mar2021, she reported it in the system on the day after she became aware since she was not able to get out of bed to report it until then. The patient experienced extremely tired, extremely sore at injection site, body aches, joint pain, fever and chills on 31Mar2021. The patient did not receive any treatment for the events. The outcome of the events recovered. Follow-up attempts are completed. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: This is a spontaneous case received from a contactable consumer (patient). A 52-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection, #lot: EL3248) via an unspecified route of administration administered in Arm Left on 30Mar2021 15:30 (at the age of 52-years-old) as single dose for COVID-19 immunization. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection, #lot: EL3248) via an unspecified route of administration administered in Arm Left on 09Mar2021 15:15 (at the age of 52-years-old) as single dose for COVID-19 immunization and allergies to medications, food, or other products with amoxicillin. The patient's concomitant medications included loratadine (CLARITINE). It was reported that the patient became aware of the AE on 31Mar2021, she reported it in the system on the day after she became aware since she was not able to get out of bed to report it until then. The patient experienced extremely tired, extremely sore at injection site, body aches, joint pain, fever and chills on 31Mar2021. The patient did not receive any treatment for the events. The outcome of the events recovered. Follow-up attempts are completed. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Nasopharyngitis
Clinical narrative: since she had cold since Thursday; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received as first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number: Unknown), via an unspecified route of administration on an unspecified date as single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, Consumer stated that, I am calling because I am scheduled to have my second Covid Vaccine shot tomorrow. I have been battling a cold from the past week and had cold since Thursday, I am at the end of the cold. So, I just want to make sure, I can still get a shot even though I still have some symptoms of the cold. I am on the end of it not in the beginning. Outcome of the event was not recovered.     No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Joint swelling
Clinical narrative: This is a spontaneous report from a contactable consumer or other non hcp (Patient). A 46-years-old female patient received first dose of bnt162b2 (BNT162B2, PFIZER-BIOTECH COVID-19 VACCNE, solution for injection, Batch/Lot Number: EL9266), via intramuscular route of administration on 11Feb2021 09:30 as single dose, for covid-19 immunization. (Vaccination facility: Hospital). (Vaccine administered at military facility: No). Patient medical history was reported as none. Family Medical history was that her father died heart attack(58years), mother high blood pressure, glaucoma, (Mother side) Grandmother (Heart Attack, died 72), (Father side) Grand Mother (Heart Attack, Diabetes). 75 died, (Father side) Grand Father, Heart Attack (78 died). The patient concomitant medications were not reported. patient did not receive any other vaccine within 4 weeks. Patient also received second dose of bnt162b2: Lot no. EN6202, Route of administration: intramuscular received on 03Mar2021. On unspecified date the patient experienced swollen and pain in joints. The outcome for the events swollen and pain in joints was reported as unknown. No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Anosmia, Chills, Fatigue, Headache, Illness
Clinical narrative: This is a spontaneous report from a contactable consumer (Patient). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported), via an unspecified route of administration on 24Mar2021 as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient and her husband received the first dose of the COVID-19 vaccine on 24Mar2021, that same day at 12 she took a COVID-19 test and tested negative, three hours later she and her husband received the first dose of the vaccine, that night(24Mar2021) she started to develop chills, next day(25Mar2021) she woke up sick presenting the following symptoms: headache, body aches, sneezing, these side effects lasted for over 5 days on which she stayed in bed, at the time patient thought this was a reaction to the vaccination. Patient also had loss of the sense of smell and fatigue. From 8 to 10 days after receiving the first dose of the vaccine they both took a COVID-19 test (on Monday) and tested positive, none of them had any social contact after the vaccination. Patient wants to know if the Pfizer COVID-19 vaccine could make patients test positive for a COVID-19 test. Outcome of events Sick, headache, body aches and sneezing resolved on 30Mar2021 and for other events outcome was unknown.No follow-up attempts are possible; information about lot/batch cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Pain, SARS-CoV-2 test, SARS-CoV-2 test positive, Sneezing
Clinical narrative: This is a spontaneous report from a contactable consumer (Patient). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported), via an unspecified route of administration on 24Mar2021 as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient and her husband received the first dose of the COVID-19 vaccine on 24Mar2021, that same day at 12 she took a COVID-19 test and tested negative, three hours later she and her husband received the first dose of the vaccine, that night(24Mar2021) she started to develop chills, next day(25Mar2021) she woke up sick presenting the following symptoms: headache, body aches, sneezing, these side effects lasted for over 5 days on which she stayed in bed, at the time patient thought this was a reaction to the vaccination. Patient also had loss of the sense of smell and fatigue. From 8 to 10 days after receiving the first dose of the vaccine they both took a COVID-19 test (on Monday) and tested positive, none of them had any social contact after the vaccination. Patient wants to know if the Pfizer COVID-19 vaccine could make patients test positive for a COVID-19 test. Outcome of events Sick, headache, body aches and sneezing resolved on 30Mar2021 and for other events outcome was unknown.No follow-up attempts are possible; information about lot/batch cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Exposure to SARS-CoV-2, Malaise, SARS-CoV-2 test
Clinical narrative: not feeling very great; I was exposed; This is a spontaneous report from a contactable consumer or other non hcp. This consumer reported for himself that a 29-years-old male patient received bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot number: not reported), dose 1 via an unspecified route of administration on 30Mar2021 (last Tuesday) as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unknown date in Apr2021, the patient was exposed, On 07Apr2021, not feeling very great. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on. On Friday 02Apr2021, and Monday 05Apr2021, I was exposed.  (At the point of this report) today, 07Apr2021, I am not feeling very great. We did buy rapid tests for our business here and I took two and they both came back negative. The clinical outcome of both events were unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Malaise, Pain in extremity, Pyrexia
Clinical narrative: Low grade fever; Arm is hurting; I felt funny; I just don't feel good; This is a spontaneous report from a contactable consumer (patient) or other non hcp. A 72-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: ER8727; Expiration Date: 31Jul2021), dose 2 via an unspecified route of administration, administered in Arm Left on 31Mar2021 (at the age of 72-years-old) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included hypertension (Verbatim: Blood pressure high), thyroid disorder (Verbatim: Thyroid) and taking medication for it. The patient's concomitant medications were not reported. The patient previously received dose 1 of bnt162b2  in arm left on an unknown date for COVID-19 immunization (lot number: EN6207). Consumer stated, ''She got her second dose 31Mar2021, came home and I was fine. But then I woke up this morning and my arm is hurting and I felt funny and then I got a low grade fever. So, I feel like I just don't feel good (on 01Apr2021''. Outcome of all the events was unknown.  No follow up attempts is needed. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Erythema, Feeling hot, Pyrexia
Clinical narrative: Fever of 99.6; Legs are red hot; Legs are red hot; This is the spontaneous report received from consumer (patient). A 80-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, batch/lot number: unspecified), via an unspecified route of administration on an unspecified date in Apr2021 afternoon as single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. On an unspecified date in Apr2021, the patients legs were red hot and had a fever of 99.6, tonight. The patient had no idea. He was just informed that come back in three weeks for the second shot. The patient did not receive any treatment to treat adverse event. No lab test was performed. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Dizziness, Gait disturbance
Clinical narrative: This is a spontaneous report from a contactable consumer or other non hcp. This consumer (patient) reported that a 56-years-old non-pregnant female patient received bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot number: ER8733), dose 1 via an unspecified route of administration, administered in Arm Left on 29Mar2021 13:30 as DOSE 1, SINGLE for covid-19 immunisation. Medical history included Neurocardiogenic syncope, history of femoral hernia repair, MVP, bursitis RT shoulder, history pinched nerve in neck, Femoral hernia repair, bursitis right shoulder, Pinched nerve in neck, Allergies to medications and foods include Sulfa, squid and octopus. Concomitant medication included sertraline hydrochloride (SERTRALINE HYDROCHLORIDE), ascorbic acid, betacarotene, biotin, calcium lactate, choline bitartrate, chromium nicotinate, colecalciferol, cyanocobalamin, dexpanthenol, dl-selenomethionine, folic acid, inositol, magnesium lactate, manganese gluconate, nicotinamide, potassium citrate, potassium iodide, pyridoxine hydrochloride, retinol palmitate, riboflavin phosphate, thiamine hydrochloride, tocopheryl acetate, zinc gluconate (MULTI VITAMIN & MINERAL) and bifidobacterium bifidum, bifidobacterium lactis, lactobacillus acidophilus, lactobacillus brevis, lactobacillus bulgaricus, lactobacillus casei lactobacillus paracasei, lactobacillus plantarum, lactobacillus rhamnosus, lactobacillus salivarius (PROBIOTIC 10). On 29Mar2021 07:00, the patient experienced had a partial day of feeling unbalanced, felt dizzy a couple of times; i didnt fall but walked with arm around husband and his around me for a while and lightheaded. It was reported that night of vaccine on a walk, felt dizzy a couple of times. In a way I havent felt before. I didnt fall but walked with arm around husband and his around me for a while. A week after shot, had a partial day of feeling unbalanced, lightheaded. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has been not tested for COVID-19. The clinical outcome of all events were unknown. No follow-up attempts are needed. No further information is expected.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Chills, Dyspnoea, Dysstasia, Gait disturbance
Clinical narrative: some shortness of breath; Chills; body aches (in the chest and the back of the neck; soreness at injection site; Chest ache; increase in shortness of breath (having difficulty standing up and moving around; increase in shortness of breath (having difficulty standing up and moving around; This is a spontaneous report from a contactable consumer (patient self-reported). A 23-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: ER8729 and expiry date was not reported), via an unspecified route of administration, in Arm Left, on 09Apr2021 at 01:30 PM (age at vaccination: 23 years), as a single dose for COVID-19 immunization at school or student health clinic. The patient's medical history and concomitant medications were not reported. The patient did not have any known allergies and allergies to medications, food, or other products. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EP6955 and expiry date was not reported), via an unspecified route of administration, in Arm Left, on 19Mar2021 at 01:30 PM (age at vaccination: 23 years), as a single dose for COVID-19 immunization at school or student health clinic. The patient did not receive any other vaccine in four weeks. The patient was not pregnant at the time of vaccination. The patient was not diagnosed with COVID prior vaccination. The patient was not tested for COVID post vaccination. The patient reported that on 10Apr2021, the patient experienced chills, body aches (in the chest and the back of the neck), soreness at injection site, some shortness of breath, chest ache, increase in shortness of breath (having difficulty standing up and moving around). The adverse events resulted in doctor or other healthcare professional office/clinic visit. It was unknown if patient received treatment for the adverse event. Outcome of the events was recovering.  Information on Lot/Batch number was available. Additional information has been requested. Follow-up attempts completed. No further information expected.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Vaccination site reaction
Clinical narrative: some shortness of breath; Chills; body aches (in the chest and the back of the neck; soreness at injection site; Chest ache; increase in shortness of breath (having difficulty standing up and moving around; increase in shortness of breath (having difficulty standing up and moving around; This is a spontaneous report from a contactable consumer (patient self-reported). A 23-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: ER8729 and expiry date was not reported), via an unspecified route of administration, in Arm Left, on 09Apr2021 at 01:30 PM (age at vaccination: 23 years), as a single dose for COVID-19 immunization at school or student health clinic. The patient's medical history and concomitant medications were not reported. The patient did not have any known allergies and allergies to medications, food, or other products. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EP6955 and expiry date was not reported), via an unspecified route of administration, in Arm Left, on 19Mar2021 at 01:30 PM (age at vaccination: 23 years), as a single dose for COVID-19 immunization at school or student health clinic. The patient did not receive any other vaccine in four weeks. The patient was not pregnant at the time of vaccination. The patient was not diagnosed with COVID prior vaccination. The patient was not tested for COVID post vaccination. The patient reported that on 10Apr2021, the patient experienced chills, body aches (in the chest and the back of the neck), soreness at injection site, some shortness of breath, chest ache, increase in shortness of breath (having difficulty standing up and moving around). The adverse events resulted in doctor or other healthcare professional office/clinic visit. It was unknown if patient received treatment for the adverse event. Outcome of the events was recovering.  Information on Lot/Batch number was available. Additional information has been requested. Follow-up attempts completed. No further information expected.
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Inappropriate schedule of product administration, Product dose omission issue, SARS-CoV-2 test
Clinical narrative: tested positive a week after receiving the 1st dose of covid-19 vaccine last 02Feb2021; he missed the 2nd dose schedule which was 17Feb2021; The schedule is also less than 21 days; This is a spontaneous report from a contactable consumer (patient) via Pfizer sponsored Program  A male patient of unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: Unknown), via an unspecified route of administration on 02Feb2021, as dose 1, single, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, a week after the first dose of vaccine, the patient was tested positive for COVID-19. The patient missed the 2nd dose schedule which was 17Feb2021; and the schedule is also less than 21 days. The patient underwent lab test and procedure which included SARS-COV-2 test: positive, on an unspecified date. The clinical outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 19.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: I tested positive for COVID.; This is a spontaneous report from a contactable consumer (Patient). A 19-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection; Lot Number: E22613, Expiration date: Unknown), via an unspecified route of administration (at the age of 19-years-old) on 24Mar2021 as dose 1, single for COVID-19 immunization. No medical history and concomitant medications were reported. It was reported that the patient tested positive for COVID on 04Apr2021. The patient underwent lab test which included SARS-CoV-2 test: Positive (Covid test) on 04Apr2021. Patient was wondering how should go about the vaccine process now. When asked for NDC, UPC and Expiry date, the patient stated that this was all she had. Product Complaint was reported as Yes. The outcome of the event was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 19.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 antibody test positive
Clinical narrative: I tested positive for COVID.; This is a spontaneous report from a contactable consumer (Patient). A 19-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection; Lot Number: E22613, Expiration date: Unknown), via an unspecified route of administration (at the age of 19-years-old) on 24Mar2021 as dose 1, single for COVID-19 immunization. No medical history and concomitant medications were reported. It was reported that the patient tested positive for COVID on 04Apr2021. The patient underwent lab test which included SARS-CoV-2 test: Positive (Covid test) on 04Apr2021. Patient was wondering how should go about the vaccine process now. When asked for NDC, UPC and Expiry date, the patient stated that this was all she had. Product Complaint was reported as Yes. The outcome of the event was unknown.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Swelling of eyelid
Clinical narrative: Area around eyes beginning to swell; This is a spontaneous report from a contactable consumer. A 65 (unspecified units) age of female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: unknown), via an unspecified route of administration on 15Apr2021 as UNKNOWN DOSE, SINGLE for COVID-19 immunization. The patient medical history and concomitant medication were not reported. On an unspecified date, the patient had experienced area around eyes beginning to swell. The outcome of the event was unknown.  Follow-up (27Apr2021): This is a follow-up spontaneous report received in response to the mail sent regarding the confirmation of below mentioned query. This response included: Screenshot attached.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: positive covid-19 test with symptoms; This is a spontaneous report from a contactable other healthcare professional. A 29-years-old female patient (non-pregnant) received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: ER8733, Expiry date was not reported),  via an unspecified route of administration, administered in left arm on 12Apr2021 11:30 (at 29-years-old)  as dose 1, single for covid-19 immunisation in the hospital. Medical history included irritable bowel syndrome (IBS) and onion allergy. The patient's concomitant medications were not reported.  The patient previously took Junel for birth control. The patient did not receive any vaccine within 4 weeks prior to covid-19 vaccine administration. Prior to vaccination, the patient has not been tested for covid-19. On 13Apr2021, the patient experienced headache, loss of taste, cold like symptoms, stuffy nose, runny nose and sore throat. It was reported that the patient tested positive for COVID 19 via rapid test on 17Apr2021 at 6.30pm after exhibiting loss of taste and "cold like" symptoms earlier in the week after receiving the first dose on Monday 12Apr2021. These symptoms included chills, stuffy nose, runny nose, sore throat and headache. Laboratory test on 17Apr2021 included SARS-CoV-2 test (rapid test) and result was positive. There was no treatment received for the reported event. Outcome of the event was reported as not recovered.  Follow-up attempts are possible. Further information is expected.